CSIMarket
 


Achilles Therapeutics Plc  (ACHL)
Other Ticker:  
 

Achilles Therapeutics Plc's Long Term Debt to Equity

ACHL's quarterly Long Term Debt to Equity and Long Term Debt, Equity growth


In the forth quarter 2022 Achilles Therapeutics Plc did not have Long Term Debt.

Within Biotechnology & Pharmaceuticals industry Achilles Therapeutics Plc achieved the lowest Long Term Debt to Equity in the forth quarter 2022. While total ranking remained the same in the forth quarter 2022 compared to the previous quarter at no. .

Explain Long Term Debt to Equity Ratio?
How much Long Term Debt ACHL´s has?
What is the structure of ACHL´s Equity?


ACHL Long Term Debt to Equity (Dec 31 2022)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2021)
IV. Quarter
Y / Y Equity Change -31.94 % -31.94 % -31.94 % -31.94 % -
Y / Y Long Term Debt Change - - - - -
Long Term Debt to Equity MRQ - - - - -
ACHL's Total Ranking # # # # #
Seq. Equity Change 0 % 0 % 0 % -31.94 % 0 %
Seq. Long Term Debt Change - - - - -



Long Term Debt to Equity forth quarter 2022 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall Market #


Long Term Debt to Equity Statistics
High Average Low
0 0 0
 




Financial Statements
Achilles Therapeutics Plc's Equity $ 197 Millions Visit ACHL's Balance sheet
Achilles Therapeutics Plc's Long Term Debt $ 0 Millions Visit ACHL's Balance sheet
Source of ACHL's Sales Visit ACHL's Sales by Geography


Cumulative Achilles Therapeutics Plc's Long Term Debt to Equity

ACHL's Long Term Debt to Equity for the trailling 12 Months

ACHL Long Term Debt to Equity

(Dec 31 2022)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2021)
IV. Quarter
Y / Y Equity TTM Growth -31.94 % -31.94 % -31.94 % -31.94 % -
Y / Y Long Term Debt TTM Growth - - - - -
Long Term Debt to Equity TTM - - - - -
Total Ranking TTM
Seq. Equity TTM Growth 0 % 0 % 0 % -31.94 % 0 %
Seq. Long Term Debt TTM Growth - - - - -


On the trailing twelve months basis During the twelve months ending IV Quarter 2022 Achilles Therapeutics Plc did not have Long Term Debt .
Long Term Debt to Equity is the average cumulative value over the last four quarters.

Among companies in the Biotechnology & Pharmaceuticals industry ACHL recorded the lowest Long Term Debt to Equity. While total ranking remained unchanged compared to previous 12 month period at no. 0.

Explain Long Term Debt to Equity Ratio?
How much Long Term Debt ACHL´s has?
What is the structure of ACHL´s Equity?

TTM Long Term Debt to Equity Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Within the Market #


trailing twelve months Long Term Debt to Equity Statistics
High Average Low
0 0 0
 




Companies with similar Long Term Debt to Equity in the quarter ending Dec 31 2022, within Biotechnology & Pharmaceuticals Industry Long Term Debt to EquityDec 31 2022 MRQ Long Term DebtDec 31 2022 MRQ Equity

Date modified: 2023-03-23T07:01:17+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com